Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC): A Mixed Treatment Comparison (MTC)
| Autor: | N Paracha, N Irahara, C Schuhmacher |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry Clinical effectiveness Health Policy Public Health Environmental and Occupational Health Treatment comparison medicine.disease Metastatic breast cancer chemistry.chemical_compound chemistry Trastuzumab emtansine Internal medicine Medicine business Previously treated |
| Zdroj: | Value in Health. 20:A416 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2017.08.108 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect